브레인스웨이 (BWAY) 주가

브레인스웨이(BWAY)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $13.63 (+0.74%), 시가총액 $0.61B, PER (주가수익비율) 69.45, 52주 최저~최고 $10.19 ~ $26.04.

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

핵심 지표

• 현재가: $13.63 (+0.74%)
• 시가총액: $0.61B
• PER (주가수익비율): 69.45
• 52주 최저~최고: $10.19 ~ $26.04
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

브레인스웨이의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

브레인스웨이 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.75

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 8.07
• 순이익률: 0.16%
• 영업이익률: 0.13%

자주 묻는 질문